清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Pan-cancer analysis shows that BCAP31 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types

癌症 生物标志物 医学 肿瘤科 癌症免疫疗法 内科学 免疫疗法 癌症研究 生物 生物化学
作者
Yangyong Sun,Zhi Li,Jianchao Liu,Ying Xiao,Yaqiang Pan,Bin Lv,Xufeng Wang,Zhiqiang Lin
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:15: 1507375-1507375 被引量:2
标识
DOI:10.3389/fimmu.2024.1507375
摘要

Background B-cell receptor-associated protein 31 (BCAP31) is a widely expressed transmembrane protein primarily located in the endoplasmic reticulum (ER), including the ER-mitochondria associated membranes. Emerging evidence suggests that BCAP31 may play a role in cancer development and progression, although its specific effects across different cancer types remain incompletely understood. Methods The raw data on BCAP31 expression in tumor and adjacent non-tumor (paracancerous) samples were obtained from the Broad Institute Cancer Cell Line Encyclopedia (CCLE) and UCSC databases. We also examined the association between BCAP31 expression and clinicopathological factors. Using the Cox proportional hazards model, we found that high BCAP31 levels were linked to poor prognosis. To further explore BCAP31’s role, we analyzed the relationship between copy number variations (CNV) and BCAP31 mRNA expression using data from The Cancer Genome Atlas (TCGA). Additionally, the association between BCAP31 expression and signature pathway scores from the MsigDB database provided insights into the tumor biology and immunological characteristics of BCAP31.We assessed the relationship between tumor immune infiltration and BCAP31 expression using the TIMER2 and ImmuCellAI databases. The ESTIMATE computational method was employed to estimate the proportion of immune cells infiltrating the tumors, as well as the stromal and immune components, based on TCGA data. To investigate drug sensitivity in relation to BCAP31 expression, we utilized GDSC2 data, which included responses to 198 medications. We explored the relationship between BCAP31 gene expression and response to immunotherapy. Additionally, the study involved culturing KYSE-150 cells under standard conditions and using siRNA-mediated knockdown of BCAP31 to assess its function. Key experiments included Western blotting (WB) to confirm BCAP31 knockdown, MTT assays for cell proliferation, colony formation assays for growth potential, Transwell assays for migration and invasion, and wound healing assays for motility. Additionally, immunohistochemistry (IHC) was performed on tumor and adjacent normal tissue samples to evaluate BCAP31 expression levels. Results BCAP31 was found to be significantly overexpressed in several prevalent malignancies and was associated with poor prognosis. Cox regression analysis across all cancer types revealed that higher BCAP31 levels were predominantly linked to worse overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI). In most malignancies, increased BCAP31 expression was positively correlated with higher CNV. Additionally, BCAP31 expression was strongly associated with the tumor microenvironment (TME), influencing the levels of infiltrating immune cells, immune-related genes, and immune-related pathways. Drug sensitivity analysis identified six medications that showed a significant positive correlation with BCAP31 expression. Furthermore, BCAP31 expression impacted the outcomes and prognosis of cancer patients undergoing immune therapy. The functional assays demonstrated that BCAP31 knockdown in KYSE-150 cells significantly inhibited cell migration, invasion, and proliferation while enhancing colony formation ability. WB and immunohistochemistry analyses confirmed elevated BCAP31 expression in tumor tissues compared to adjacent normal tissues in esophageal cancer, lung adenocarcinoma, and gastric adenocarcinoma. Conclusion BCAP31 has the potential to serve as a biomarker for cancer immunology, particularly in relation to immune cell infiltration, and as an indicator of poor prognosis. These findings provide a new perspective that could inform the development of more targeted cancer therapy strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形的灵薇完成签到,获得积分10
16秒前
mickaqi完成签到 ,获得积分10
21秒前
柔弱的妙旋完成签到,获得积分10
30秒前
limengyao完成签到,获得积分10
54秒前
lzm完成签到 ,获得积分10
56秒前
水water完成签到 ,获得积分10
1分钟前
虎子完成签到 ,获得积分10
1分钟前
激情的汲完成签到,获得积分10
1分钟前
小珂完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
Gone完成签到,获得积分10
1分钟前
SciGPT的应助被兰兰不懒采纳,获得10
1分钟前
1分钟前
yc关闭了yc的文献求助
2分钟前
VuuVuu完成签到,获得积分10
2分钟前
顺利的雅旋完成签到,获得积分10
2分钟前
2分钟前
兰兰不懒发布了新的文献求助10
2分钟前
淡淡依霜完成签到 ,获得积分10
2分钟前
廖道罡完成签到,获得积分10
2分钟前
温婉的乐荷完成签到,获得积分10
2分钟前
VuuVuu发布了新的文献求助10
2分钟前
852的应助被LY采纳,获得10
3分钟前
简单完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
isssstwice发布了新的文献求助30
3分钟前
isssstwice完成签到,获得积分10
4分钟前
doudou完成签到,获得积分10
4分钟前
落后的山槐完成签到,获得积分10
4分钟前
5分钟前
LY发布了新的文献求助10
5分钟前
活力尔柳完成签到 ,获得积分10
5分钟前
lilylwy完成签到 ,获得积分0
5分钟前
朝朝的应助被萧雨墨采纳,获得10
5分钟前
单纯的天抒完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190226
求助须知:如何正确求助?哪些是违规求助? 9577355
关于积分的说明 21852358
捐赠科研通 7788741
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560106
邀请新用户注册赠送积分活动 2482902